Prostate Biopsy Tumor Extent but Not Location Predicts Recurrence After Radical Prostatectomy: Results From CaPSURE-Reference-Cited by-同舟云学术

Prostate Biopsy Tumor Extent but Not Location Predicts Recurrence After Radical Prostatectomy: Results From CaPSURE

Published:2006-01 Issue:1 Volume:175 Page:125-129
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Greene Kirsten L.¹,Elkin Eric P.¹,Karapetian Armine¹,DuChane Janeen²,Carroll Peter R.¹,Kane Christopher J.³,

Affiliation:

1. Department of Urology, University of California, San Francisco Comprehensive Cancer Center, University of California, San Francisco

2. TAP Pharmaceutical Products, Inc., Lake Forest, Illinois

3. San Francisco Veterans Affairs Medical Center, San Francisco, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Time trends in clinical risk stratification for prostate cancer;Cooperberg;J Urol,2003

2. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

3. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer;Graefen;J Urol,2004

4. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy;Grossfeld;J Urol,2001

5. Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer;D’Amico;Mol Urol,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men;Frontiers in Oncology;2013

2. Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance;European Urology;2011-03

3. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?;Urologic Oncology: Seminars and Original Investigations;2011-03

4. Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme;BJU International;2010-12-22

5. Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone;Brachytherapy;2010-10